2012 NHIA Annual Conference & Exposition
2012 NHIA Roundtables
Bigger and better than ever! TWO SESSIONS of CE-approved Roundtables double the time you can spend with peers and industry experts, as you share ideas about ongoing challenges and new opportunities!
For those in need of pharmacy or nursing continuing education credits, you can obtain a total of 3.0 contact hours when you attend both nights of the 2012 NHIA Roundtables program.
Choose up to SIX subjects that fit your interests best during these two highly interactive 90-minute sessions.
Engage in dynamic fellowship and education, as you network with both friends and colleagues during the 2012 NHIA Roundtables program...
- Shared-learning with industry experts and your peers is one of the most valuable aspects of attending the NHIA Annual Conference—and the Roundtables format provides a unique gathering where you and your team can ask vital questions, and share your own thoughts about the most critical issues in alternate-site infusion today.
- Dialogue about our industry's "hottest topics" in clinical care, leadership and management, reimbursement, and sales and marketing—while gaining tangible information and strategic insights you can implement upon your return to the office! Roundtables.
Tuesday, April 24
Roundtables Session I
5:00 – 6:30 PM
Phoenix Convention Center
Continuing Education Contact Hours:
Pharmacy and Nursing—1.5*
Supported by an educational grant from RMS Medical Products
Wednesday, April 25
Roundtables Session II
4:15 – 5:45 PM
Phoenix Convention Center
Continuing Education Contact Hours:
Pharmacy and Nursing—1.5*
Supported by an educational grant from Bard Access Systems
Most subjects will be repeated in the 2nd session, ensuring you don't miss out on a critical topic of interest!
2012 NHIA Roundtable Topics Already Include…
| 5010 Implementation and Electronic Claims Challenges |
| Achieving the Right Balance of “Clinical” and “Sales” within the Clinical Liaison Role |
| Becoming a Clinical Rotation Site for Your Local School of Pharmacy |
| Brainstorming Alternate-Site Infusion Recruitment, Retention and Staffing Methods |
| Challenging Demands on Delivery Hardware in the New SCIG Environment |
| Clinical Perspective of Payer Audits |
| Conducting a Clinical Research Trial in the Home Infusion Setting |
| Drug Shortages |
| Estates, Bankruptcy & Self-Pay Collections |
| Ethics in Home Infusion Sales and Marketing |
| Getting Paid What You Expect from Your Contracts |
| HIPAA: “The Elephant In the Room”—Enhancing Your Comprehension of the Healthcare Insurance Portability and Accountability Act to Better Identify Risks and Solutions |
| ICD-10 (International Classification of Diseases, Tenth Revision) Conversion—How Are You Preparing? |
| Implanted Port Access Challenges—From Sterility to Stabilization |
| Improving Patient and Health System Outcomes through Advanced Pharmacy Practice |
| Industry Move to ASP Pricing and Other Pricing Pressures |
| Infection Control in the Home |
| Infusion Focused Selling 101 |
| Intake Strategies That Produce Clean Claims |
| Internal Auditing—Ensuring All Your “I’s” are Dotted and “T’s” Are Crossed Before a Payer Audit |
| Management of Chronic Lyme Disease |
| Managing Enteral Feeding Tubes in the Home |
| Managing Sales Turnover, Orientation, Culture |
| Measuring Outcomes in Home Infusion |
| Medicare Competitive Bidding: My bid is in. What’s next? |
| Medicare Documentation: Strategies for Successful Appeals and Timely Reimbursement |
| Medication Adherence |
| Micronutrient Assessment |
| National Supplier Clearinghouse: Hot Topics in Medicare Enrollment |
| Navigating Sales Turnover—Determining a Course for Success |
| Outcomes Data Collection Tools for Central Vascular Access Devices (CVADs) |
| Paperless Charts in Home Infusion |
| Partnering with Home Health Agencies to Develop and Maintain Nurse Competency |
| Revenue Cycle Productivity—Indicators and Best Practices |
| Safely Outsourcing High-Risk Compounding |
| Six Sigma Cash Collections |
| Successfully Negotiating Commercial Health Plan Contracts for Medical Coverage and Drug Carve Outs |
| Troubleshooting NCPDP (National Council for Prescription Drug Programs) Rejections |
| USP 797 Compliance—the Gray and Challenging Areas |
| Vancomycin Dosing Guidelines |